Liu Hangsheng, Phelps Charles E
Department of Community and Preventive Medicine, University of Rochester, 601 Elmwood Avenue, Box 644, Rochester, NY 14642, USA.
Health Serv Res. 2008 Jun;43(3):971-87. doi: 10.1111/j.1475-6773.2007.00805.x.
To examine the effect of nonprice competition among managed care plans on the quality of care in the New York SCHIP market.
U.S. Census 2000; 2002 New York State Managed Care Plan Performance Report; and 2001 New York State Managed Care Annual Enrollment Report.
Each market is defined as a county, and competition is measured as the number of plans in a market. Quality of care is measured in percentages using three Consumer Assessment of Health Plans Survey and three Health Plan Employer Data and Information Set scores. Two-stage least squares is applied to address the endogeneity between competition and the quality of care, using population as an instrument.
We find a negative association between competition and quality of care. An additional managed care plan is significantly associated with a decrease of 0.40-2.31 percentage points in four out of six quality measures. After adjusting for production cost, a positive correlation is observed between price and quality measures across different pricing regions.
It seems likely that pricing policy is a constraint on quality production, although it may not be interpreted as a causal relationship and further study is needed.
研究管理式医疗计划之间的非价格竞争对纽约儿童健康保险计划(SCHIP)市场医疗质量的影响。
2000年美国人口普查;《2002年纽约州管理式医疗计划绩效报告》;以及《2001年纽约州管理式医疗年度参保报告》。
每个市场定义为一个县,竞争程度以市场中的计划数量衡量。医疗质量通过三项健康计划消费者评估调查和三项健康计划雇主数据与信息集得分的百分比来衡量。采用两阶段最小二乘法,以人口作为工具变量来处理竞争与医疗质量之间的内生性问题。
我们发现竞争与医疗质量之间存在负相关。每增加一个管理式医疗计划,在六项质量指标中的四项上,显著导致质量下降0.40 - 2.31个百分点。在调整生产成本后,不同定价区域的价格与质量指标之间呈现正相关。
定价政策似乎是质量产出的一个制约因素,尽管这不能被解释为因果关系,还需要进一步研究。